Literature DB >> 19669350

Unrevealing the natural course of the so-called "inactive HBsAg or HBV carrier state".

Stephanos J Hadziyannis1.   

Abstract

Year:  2007        PMID： 19669350      PMCID： PMC2716827          DOI： 10.1007/s12072-007-9004-7

Source DB:  PubMed          Journal:  Hepatol Int        ISSN： 1936-0533            Impact factor:   6.047


× No keyword cloud information.
  34 in total

Review 1.  Hepatitis B e antigen-negative chronic hepatitis B.

Authors:  S J Hadziyannis; D Vassilopoulos
Journal:  Hepatology       Date:  2001-10       Impact factor: 17.425

Review 2.  Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update.

Authors:  Yun-Fan Liaw; Nancy Leung; Richard Guan; George K K Lau; Ismail Merican; Geoff McCaughan; Edward Gane; Jia-Horng Kao; Masao Omata
Journal:  Liver Int       Date:  2005-06       Impact factor: 5.828

3.  Chronic hepatitis B.

Authors:  Anna S F Lok; Brian J McMahon
Journal:  Hepatology       Date:  2007-02       Impact factor: 17.425

4.  Cytoplasmic hepatitis B antigen in "ground-glass" hepatocytes of carriers.

Authors:  S Hadziyannis; M A Gerber; C Vissoulis; H Popper
Journal:  Arch Pathol       Date:  1973-11

5.  Prevalence of hepatitis B e antigen and its antibody as detected by radioimmunoassays.

Authors:  I K Mushahwar; L R Overby; G Frosner; F Deinhardt; C M Ling
Journal:  J Med Virol       Date:  1978       Impact factor: 2.327

Review 6.  A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update.

Authors:  Emmet B Keeffe; Douglas T Dieterich; Steven-Huy B Han; Ira M Jacobson; Paul Martin; Eugene R Schiff; Hillel Tobias; Teresa L Wright
Journal:  Clin Gastroenterol Hepatol       Date:  2006-07-14       Impact factor: 11.382

7.  Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus.

Authors:  S J Hadziyannis; H M Lieberman; G G Karvountzis; D A Shafritz
Journal:  Hepatology       Date:  1983 Sep-Oct       Impact factor: 17.425

8.  Expression of pre-S gene-encoded proteins in liver and serum during chronic hepatitis B virus infection in comparison to other markers of active virus replication.

Authors:  S Hadziyannis; G Raimondo; C Papaioannou; C Anastassakos; D Wong; J Sninsky; D Shafritz
Journal:  J Hepatol       Date:  1987-12       Impact factor: 25.083

9.  A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal.

Authors:  J P Villeneuve; M Desrochers; C Infante-Rivard; B Willems; G Raymond; M Bourcier; J Côté; G Richer
Journal:  Gastroenterology       Date:  1994-04       Impact factor: 22.682

10.  Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years.

Authors:  Mauro Manno; Calogero Cammà; Filippo Schepis; Fabio Bassi; Roberta Gelmini; Francesco Giannini; Francesca Miselli; Antonella Grottola; Ilva Ferretti; Chiara Vecchi; Marisa De Palma; Erica Villa
Journal:  Gastroenterology       Date:  2004-09       Impact factor: 22.682
View more
  3 in total

Review 1.  Definition and classification of acute-on-chronic liver diseases.

Authors:  Yuan-Yao Zhang; Zhong-Ji Meng
Journal:  World J Clin Cases       Date:  2022-05-26       Impact factor: 1.534

Review 2.  HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection.

Authors:  Alexandra Alexopoulou; Peter Karayiannis
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

3.  Evaluation of Point Shear Wave Elastography Using Acoustic Radiation Force Impulse Imaging for Longitudinal Fibrosis Assessment in Patients with HBeAg-Negative HBV Infection.

Authors:  Christiana Graf; Antonia Mondorf; Viola Knop; Kai-Henrik Peiffer; Julia Dietz; Julia Friess; Heiner Wedemeyer; Peter Buggisch; Stefan Mauss; Thomas Berg; Michael Rausch; Martin Sprinzl; Hartwig Klinker; Holger Hinrichsen; Jean-Pierre Bronowicki; Sebastian Haag; Dietrich Hüppe; Thomas Lutz; Thierry Poynard; Stefan Zeuzem; Mireen Friedrich-Rust; Christoph Sarrazin; Johannes Vermehren
Journal:  J Clin Med       Date:  2019-12-02       Impact factor: 4.241
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.